Martinez Ursula, Brandon Thomas H, Warren Graham W, Simmons Vani N
Department of Health Outcomes and Behavior, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
Department of Oncologic Sciences, University of South Florida, Tampa, FL, USA.
Cancer Causes Control. 2025 Feb;36(2):127-134. doi: 10.1007/s10552-024-01931-y. Epub 2024 Oct 24.
Smoking after cancer impairs cancer treatment outcomes and prognosis, regardless of cancer type. Prior data suggest that patients with cancers other than lung or head/neck cancer had lower cessation motivation, which in turn predicted lower smoking abstinence. This study evaluated feasibility for a future efficacy trial and assessed the acceptability of brief self-help materials, targeted by cancer type, to enhance cessation motivation.
Patients had a diagnosis of skin melanoma, breast, bladder, colorectal, or gynecological cancers within ≤ 6 months, smoked ≥ 1 cigarette in the past month, and were not currently participating in a cessation program. After completing a baseline assessment, participants received the booklet corresponding to their cancer type. Follow-ups were conducted 1 week and 1 month post-intervention.
Among 118 patients potentially eligible, 109 were successfully contacted and 53 patients were eligible and all consented. Among consenting patients, 92.5% completed baseline, and 90.6% received the intervention. Among patients receiving the intervention, 91.7% completed all study procedures and follow-up. At 1 month, 87.5% reported reading the booklet and 92.8% rated it as good/excellent. Motivation to quit smoking increased over time among those with lower motivation at baseline, 33.3% sought smoking cessation assistance, and 25.0% were smoke-free 1 month post-intervention.
This study demonstrated the feasibility and acceptability of the first intervention developed for patients with cancers not typically associated with smoking. This low-cost and easy to disseminate intervention has potential to increase motivation to quit smoking among patients with cancers not typically perceived as smoking-related.
癌症患者吸烟会损害癌症治疗效果和预后,无论癌症类型如何。先前的数据表明,除肺癌或头颈癌以外的其他癌症患者戒烟动机较低,这反过来又预示着较低的戒烟成功率。本研究评估了未来疗效试验的可行性,并评估了针对不同癌症类型的简短自助材料对增强戒烟动机的可接受性。
患者在≤6个月内被诊断为皮肤黑色素瘤、乳腺癌、膀胱癌、结直肠癌或妇科癌症,在过去一个月内每天吸烟≥1支,且目前未参加戒烟计划。在完成基线评估后,参与者收到与其癌症类型对应的手册。干预后1周和1个月进行随访。
在118名可能符合条件的患者中,成功联系到109名,53名患者符合条件且均同意参与。在同意参与的患者中,92.5%完成了基线评估,90.6%接受了干预。在接受干预的患者中,91.7%完成了所有研究程序和随访。在1个月时,87.5%的患者报告阅读了手册,92.8%的患者将其评为良好/优秀。基线时戒烟动机较低的患者,其戒烟动机随时间增加,33.3%的患者寻求戒烟帮助,干预后1个月25.0%的患者戒烟。
本研究证明了为非典型吸烟相关癌症患者开发的首次干预措施的可行性和可接受性。这种低成本且易于传播的干预措施有可能增加非典型吸烟相关癌症患者的戒烟动机。